The crystal structure of hexakis(3-thiophenecarboxylato-κ 2 O,O″)-bis(1,10-phenanthroline-κ 2 N,N′) trimanganese(II), C54H34N4O12S6Mn3-Reference-Cited by-同舟云学术

The crystal structure of hexakis(3-thiophenecarboxylato-κ ² O,O″)-bis(1,10-phenanthroline-κ ² N,N′) trimanganese(II), C₅₄H₃₄N₄O₁₂S₆Mn₃

Published:2023-11-01 Issue:6 Volume:238 Page:1039-1041
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Zhou Lili¹,Zhang Zhongyu¹^ORCID,Men Xiaoxia¹,Zhang Yaxuan¹

Affiliation:

1. College of Medicine and Nursing , Dezhou University , Dezhou , 253000 , Shandong , China

Abstract

Abstract C54H34N4O12S6Mn3, monoclinic, P21/c (no. 14), a = 11.0140(4) Å, b = 22.3222(9) Å, c = 11.2886(5) Å, β = 105.436(1)°, Z = 2, V = 2675.27(19) Å3, R gt (F) = 0.0361, wR ref (F 2) = 0.0846, T = 273 K.

Funder

Transverse Research Project of Dezhou University

Bidding Subject of Dezhou University

Shandong Province College Students Innovation and Entrepreneurship Training Program Project

Publisher

Walter de Gruyter GmbH

Subject

Inorganic Chemistry,Condensed Matter Physics,General Materials Science

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2023-0230/pdf

Reference7 articles.

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2004.

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

3. Ndagi, U., Mhlongo, N., Soliman, M. E. Metal complexes in cancer therapy – an update from drug design perspective. Drug Des. Dev. Ther. 2017, 11, 599–616; https://doi.org/10.2147/dddt.s119488.

4. Takasaki, S., Takamizawa, S. Reversible crystal deformation of a single-crystal host of copper (II) 1-naphthoate-pyrazine through crystal phase transition induced by methanol vapor sorption. Chem. Commun. 2015, 51, 5024–5027; https://doi.org/10.1039/c4cc09948f.

5. Wei, M., Peng, X., Xing, L., Dai, Y., Huang, R., Geng, M., Zhang, A., Ai, J., Song, Z. Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-n-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors. Eur. J. Med. Chem. 2018, 154, 9–28; https://doi.org/10.1016/j.ejmech.2018.05.005.